Latest Whitepapers

This article examines how analytical scientists can enhance their data sharing and reporting practices, leading to improvements in data integrity and an easier route to compliance within a regulated good manufacturing practice (GMP) environment.

This whitepaper highlights how the latest software can help researchers overcome the uncertainties in drug discovery and enable efficient compound design, synthesis and progression tracking.

This whitepaper explores how scientists can identify and take advantage of untapped business value in existing lab data.

This whitepaper explores advanced electronic solutions to streamline your biopharmaceutical workflow and help you stay compliant.

This whitepaper explores the importance of data integrity in drug manufacturing workflows, so you stay up to date with the latest regulations.

Solid form informatics (SFI) provides a knowledge-based approach to improve the effectiveness and quality of early-phase drug discovery research, as well as a rational approach to risk assessment.

The EU GMP Annex 1 provides specific guidance on the manufacture of sterile medicinal products. Though it is a European guide for manufacturing, EU GMP Annex 1’s impact is global. So how does the latest revision affect you?

To support successful laboratory functions, access to a modern informatics suite is essential, and this can be either on-premise or a cloud-hosted solution. There is however a third option, known as Software-as-a-Service (SaaS).

A successful lab is more than a scientific hub. In today’s age, it’s a digital data enterprise. All laboratories are handling a vast amount of data which is growing exponentially day by day, creating an urgent need for an integrated informatics platform.

Using data science algorithms, AI and ML rapidly process all of that structured and unstructured LIMS data, integrating it with external enterprise data and serving lab managers and analysts with valuable insights and timely, meaningful recommendations.